Literature DB >> 25950756

Purinergic signaling and energy homeostasis in psychiatric disorders.

D Lindberg, D Shan, J Ayers-Ringler, A Oliveros, J Benitez, M Prieto, R McCullumsmith, D-S Choi1.   

Abstract

Purinergic signaling regulates numerous vital biological processes in the central nervous system (CNS). The two principle purines, ATP and adenosine act as excitatory and inhibitory neurotransmitters, respectively. Compared to other classical neurotransmitters, the role of purinergic signaling in psychiatric disorders is not well understood or appreciated. Because ATP exerts its main effect on energy homeostasis, neuronal function of ATP has been underestimated. Similarly, adenosine is primarily appreciated as a precursor of nucleotide synthesis during active cell growth and division. However, recent findings suggest that purinergic signaling may explain how neuronal activity is associated neuronal energy charge and energy homeostasis, especially in mental disorders. In this review, we provide an overview of the synaptic function of mitochondria and purines in neuromodulation, synaptic plasticity, and neuron-glia interactions. We summarize how mitochondrial and purinergic dysfunction contribute to mental illnesses such as schizophrenia, bipolar disorder, autism spectrum disorder (ASD), depression, and addiction. Finally, we discuss future implications regarding the pharmacological targeting of mitochondrial and purinergic function for the treatment of psychiatric disorders.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25950756      PMCID: PMC5036858          DOI: 10.2174/1566524015666150330163724

Source DB:  PubMed          Journal:  Curr Mol Med        ISSN: 1566-5240            Impact factor:   2.222


  221 in total

1.  Effects of mood stabilizers on mitochondrial respiratory chain activity in brain of rats treated with d-amphetamine.

Authors:  Samira S Valvassori; Gislaine T Rezin; Camila L Ferreira; Morgana Moretti; Cinara L Gonçalves; Mariana R Cardoso; Emílio L Streck; Flávio Kapczinski; João Quevedo
Journal:  J Psychiatr Res       Date:  2010-03-23       Impact factor: 4.791

2.  Mitochondrial dysfunction in autism.

Authors:  Cecilia Giulivi; Yi-Fan Zhang; Alicja Omanska-Klusek; Catherine Ross-Inta; Sarah Wong; Irva Hertz-Picciotto; Flora Tassone; Isaac N Pessah
Journal:  JAMA       Date:  2010-12-01       Impact factor: 56.272

3.  The cell-non-autonomous nature of electron transport chain-mediated longevity.

Authors:  Jenni Durieux; Suzanne Wolff; Andrew Dillin
Journal:  Cell       Date:  2011-01-07       Impact factor: 41.582

4.  In vivo 31P NMR spectroscopy shows an increase in glycerophosphorylcholine concentration without alterations in mitochondrial function in the prefrontal cortex of medicated schizophrenic patients at rest.

Authors:  Yukihiko Shirayama; Toshio Yano; Kiyohisa Takahashi; Seizo Takahashi; Takashi Ogino
Journal:  Eur J Neurosci       Date:  2004-08       Impact factor: 3.386

5.  Abnormal frontal lobe phosphorous metabolism in bipolar disorder.

Authors:  R F Deicken; G Fein; M W Weiner
Journal:  Am J Psychiatry       Date:  1995-06       Impact factor: 18.112

6.  Association analysis of adenosine A1 receptor gene (ADORA1) polymorphisms with schizophrenia in a Japanese population.

Authors:  Leo Gotoh; Hiroshi Mitsuyasu; Yuki Kobayashi; Naoya Oribe; Atsushi Takata; Hideaki Ninomiya; Vincent P Stanton; Gregory M Springett; Hiroaki Kawasaki; Shigenobu Kanba
Journal:  Psychiatr Genet       Date:  2009-12       Impact factor: 2.458

7.  Brain metabolic alterations in medication-free patients with bipolar disorder.

Authors:  Stephen R Dager; Seth D Friedman; Aimee Parow; Christina Demopulos; Andrew L Stoll; In Kyoon Lyoo; David L Dunner; Perry F Renshaw
Journal:  Arch Gen Psychiatry       Date:  2004-05

8.  Decreased brain intracellular pH measured by 31P-MRS in bipolar disorder: a confirmation in drug-free patients and correlation with white matter hyperintensity.

Authors:  T Kato; J Murashita; A Kamiya; T Shioiri; N Kato; T Inubushi
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1998       Impact factor: 5.270

9.  Desipramine activated Bcl-2 expression and inhibited lipopolysaccharide-induced apoptosis in hippocampus-derived adult neural stem cells.

Authors:  Yu-Yin Huang; Chi-Hsien Peng; Yi-Ping Yang; Chih-Chiau Wu; Wen-Ming Hsu; Hsiao-Jung Wang; Kwok-Han Chan; Yi-Pen Chou; Shih-Jen Chen; Yuh-Lih Chang
Journal:  J Pharmacol Sci       Date:  2007-05       Impact factor: 3.337

10.  Gene expression alterations in bipolar disorder postmortem brains.

Authors:  Haiming Chen; Nulang Wang; Xin Zhao; Christopher A Ross; K Sue O'Shea; Melvin G McInnis
Journal:  Bipolar Disord       Date:  2013-01-30       Impact factor: 6.744

View more
  19 in total

1.  Peripheral fibroblast metabolic pathway alterations in juvenile rhesus monkeys undergoing long-term fluoxetine administration.

Authors:  Shu-Yi Su; Casey E Hogrefe-Phi; John M Asara; Christoph W Turck; Mari S Golub
Journal:  Eur Neuropsychopharmacol       Date:  2016-04-12       Impact factor: 4.600

Review 2.  Purinergic Signalling: Therapeutic Developments.

Authors:  Geoffrey Burnstock
Journal:  Front Pharmacol       Date:  2017-09-25       Impact factor: 5.810

Review 3.  Disentangling the Role of Astrocytes in Alcohol Use Disorder.

Authors:  Louise Adermark; M Scott Bowers
Journal:  Alcohol Clin Exp Res       Date:  2016-08-01       Impact factor: 3.455

4.  Guanosine Anxiolytic-Like Effect Involves Adenosinergic and Glutamatergic Neurotransmitter Systems.

Authors:  Roberto Farina Almeida; Daniel Diniz Comasseto; Denise Barbosa Ramos; Gisele Hansel; Eduardo R Zimmer; Samanta Oliveira Loureiro; Marcelo Ganzella; Diogo Onofre Souza
Journal:  Mol Neurobiol       Date:  2016-01-07       Impact factor: 5.590

5.  Hyperuricemia in Children and Adolescents with Autism Spectrum Disorder Treated with Risperidone: The Risk Factors for Metabolic Adverse Effects.

Authors:  Natchaya Vanwong; Pornpen Srisawasdi; Nattawat Ngamsamut; Nopphadol Nuntamool; Apichaya Puangpetch; Bhunnada Chamkrachangpada; Yaowaluck Hongkaew; Penkhae Limsila; Wiranpat Kittitharaphan; Chonlaphat Sukasem
Journal:  Front Pharmacol       Date:  2017-01-05       Impact factor: 5.810

6.  Specialized Information Processing Deficits and Distinct Metabolomic Profiles Following TM-Domain Disruption of Nrg1.

Authors:  Colm M P O'Tuathaigh; Naina Mathur; Matthew J O'Callaghan; Lynsey MacIntyre; Richard Harvey; Donna Lai; John L Waddington; Benjamin S Pickard; David G Watson; Paula M Moran
Journal:  Schizophr Bull       Date:  2017-09-01       Impact factor: 9.306

Review 7.  Evidence of Mitochondrial Dysfunction in Autism: Biochemical Links, Genetic-Based Associations, and Non-Energy-Related Mechanisms.

Authors:  Keren K Griffiths; Richard J Levy
Journal:  Oxid Med Cell Longev       Date:  2017-05-29       Impact factor: 6.543

8.  Energetic Constraints Produce Self-sustained Oscillatory Dynamics in Neuronal Networks.

Authors:  Javier Burroni; P Taylor; Cassian Corey; Tengiz Vachnadze; Hava T Siegelmann
Journal:  Front Neurosci       Date:  2017-02-27       Impact factor: 4.677

Review 9.  Purinergic Signaling in Neuron-Astrocyte Interactions, Circadian Rhythms, and Alcohol Use Disorder.

Authors:  Daniel Lindberg; Lindsey Andres-Beck; Yun-Fang Jia; Seungwoo Kang; Doo-Sup Choi
Journal:  Front Physiol       Date:  2018-02-06       Impact factor: 4.566

Review 10.  Fluoxetine Administration in Juvenile Monkeys: Implications for Pharmacotherapy in Children.

Authors:  Mari S Golub; Casey E Hogrefe; Richard J Sherwood; Christoph W Turck
Journal:  Front Pediatr       Date:  2018-02-08       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.